Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Patients”

1,718 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,718 results

Not applicableLooking for participantsNCT05667064
What this trial is testing

Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Who this might be right for
Unresectable Hepatocellular Carcinoma
AstraZeneca 300
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Testing effectiveness (Phase 2)Ended earlyNCT00787787
What this trial is testing

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Washington 41
Testing effectiveness (Phase 2)Study completedNCT01271504
What this trial is testing

E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eisai Inc. 102
Testing effectiveness (Phase 2)Study completedNCT01639352
What this trial is testing

Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Lynn Feun 20
Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Early research (Phase 1)Looking for participantsNCT05791448
What this trial is testing

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Who this might be right for
Advanced CholangiocarcinomaAdvanced Hepatocellular CarcinomaAdvanced Malignant Solid Neoplasm+4 more
University of Southern California 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06239155
What this trial is testing

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Ascentawits Pharmaceuticals, Ltd 51
Early research (Phase 1)Study completedNCT00802555
What this trial is testing

Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)

Who this might be right for
CirrhosisHepatocellular Carcinoma
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 21
Not applicableLooking for participantsNCT06887348
What this trial is testing

Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Who this might be right for
MelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more
Replimune Inc. 50
Not applicableUnknownNCT05846035
What this trial is testing

Paraneoplastic Syndrome in Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma Patients
Sohag University 80
Not applicableStudy completedNCT05291338
What this trial is testing

Pharmacogenetic Study in Hepatocellular Carcinoma Patients.

Who this might be right for
Hepatocellular Carcinoma
Rehab Werida 107
Early research (Phase 1)Study completedNCT02988440
What this trial is testing

Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 20
Not applicableNot Yet RecruitingNCT07120750
What this trial is testing

Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Chronic Hepatitis B
Shenzhen Third People's Hospital 332
Testing effectiveness (Phase 2)UnknownNCT04066543
What this trial is testing

TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Carcinoma, Hepatocellular
Zhejiang Cancer Hospital 40
Not applicableStudy completedNCT00764140
What this trial is testing

Tumor Growth Factors in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 400
Not applicableNot Yet RecruitingNCT06872047
What this trial is testing

Exploring the Knowledge, Attitudes, Behaviors and Perceived Barriers of Hepatologists Towards Non-invasive Hepatocellular Carcinoma Prediction Models in Hepatitis C Patients Who Achieved Sustained Virological Response Following Direct Acting Antivirals Therapy

Who this might be right for
Non-invasive Hepatocellular Carcinoma
Assiut University 400
Not applicableStudy completedNCT01923948
What this trial is testing

Preoperative Pain Control in Liver Surgery Patients

Who this might be right for
Pain, PostoperativeHepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04157140
What this trial is testing

Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Jinglong Chen 48
Testing effectiveness (Phase 2)Ended earlyNCT01480817
What this trial is testing

Sorafenib VS TACE in HCC Patients With Portal Vein Invasion

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 2
Load More Results